GE offers off-the-shelf manufacturing plants; Valeant, Medicis combine operations;

> GE Healthcare is now selling what it calls KUBio, an off-the-shelf, 1,200-square-meter modular factory that can be quickly erected and ready to manufacture. Story

> GeneTex, the U.S. antibody producer, says it will make a new antibody against HIF1a (hypoxia-inducible factor 1alpha) that is more stable than many on the market. Item

> Under new rules in Denmark, drug manufacturers' authorization to do business will not have to be updated but will be considered valid unless regulators take steps to change them. Story

> Valeant Pharmaceuticals ($VRX) is buying dermatology specialist Medicis Pharmaceuticals for $2.6 billion. Story

And Finally... More than 50 years after its morning sickness drug Thalidomide was banned because it causes deformities in children whose mothers took it, the German drugmaker Grunenthal has apologized for its effects. Story

Suggested Articles

Neopharma, which has been buying and building plants for several years, is buying a sterile injectables plant and assets in Japan from India’s Lupin. 

Already knocked by the FDA four times this year, Dr. Reddy’s now has a fifth Form 483 to dwell on. This time it’s at a plant with a history of faults.

In a warning letter, the FDA details how a Chinese OTC drugmaker handed over documents faked just for the agency's inspection—and admitted it.